Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myasthenia Gravis Generalised”

127 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 127 results

Testing effectiveness (Phase 2)WithdrawnNCT04982289
What this trial is testing

Study of ALXN1830 Administered Subcutaneously in Adults With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc.
Not applicableLooking for participantsNCT06312644
What this trial is testing

Study of Ultomiris® (Ravulizumab) Safety in Pregnancy

Who this might be right for
Ultomiris-exposed Pregnant/ PostpartumPregnancyParoxysmal Nocturnal Hemoglobinuria (PNH)+3 more
Alexion Pharmaceuticals, Inc. 75
Large-scale testing (Phase 3)Not Yet RecruitingNCT07215949
What this trial is testing

Zilucoplan for Severe gMG Exacerbations

Who this might be right for
Generalized Myasthenia Gravis (gMG)
Miriam Freimer 15
Not applicableLooking for participantsNCT06967480
What this trial is testing

Early Ravulizumab Treatment Of Anti- AChR Antibody-Positive Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia GravisAnti-AChR Antibody Positive
Alexion Pharmaceuticals, Inc. 40
Not applicableTemporarily pausedNCT04031469
What this trial is testing

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

Who this might be right for
Gut MicrobiomeGastrointestinal MicrobiomeAutism+77 more
ProgenaBiome 1,000
Large-scale testing (Phase 3)Study completedNCT03971422
What this trial is testing

Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
UCB Biopharma SRL 200
Very early researchWithdrawnNCT06419166
What this trial is testing

An Exploratory Clinical Study of GC012F Injection for Refractory gMG

Who this might be right for
Refractory Generalized Myasthenia Gravis
Zhejiang University
Large-scale testing (Phase 3)Looking for participantsNCT05868837
What this trial is testing

Rituximab EfFicacy IN MyasthEnia Gravis (REFINE)

Who this might be right for
Myasthenia Gravis, Generalized
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 40
Post-approval studies (Phase 4)Study completedNCT00987116
What this trial is testing

Study Comparing Two Tapering Strategies of Prednisone in Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Assistance Publique - Hôpitaux de Paris 118
Large-scale testing (Phase 3)Active Not RecruitingNCT04951622
What this trial is testing

Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Janssen Research & Development, LLC 219
Not applicableLooking for participantsNCT06685055
What this trial is testing

Markers of Favorable Response to FcRn Inhibitors(INFORM)

Who this might be right for
Myasthenia Gravis Generalized
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 50
Post-approval studies (Phase 4)Looking for participantsNCT07246564
What this trial is testing

Phase 4 Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Chinese Participants With Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
UCB Biopharma SRL 40
Large-scale testing (Phase 3)Study completedNCT04735432
What this trial is testing

Evaluating the Pharmacodynamic Noninferiority of Efgartigimod PH20 SC Administered Subcutaneously as Compared to Efgartigimod Administered Intravenously in Patients With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
argenx 110
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07372807
What this trial is testing

Ripertamab for the Treatment of Myasthenia Gravis

Who this might be right for
Myasthenia Gravis (MG)
Zhongming Qiu 20
Post-approval studies (Phase 4)Looking for participantsNCT06909214
What this trial is testing

Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG)

Who this might be right for
New Onset Generalized Myasthenia Gravis (gMG)
argenx 30
Early research (Phase 1)Looking for participantsNCT07215650
What this trial is testing

Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG)

Who this might be right for
Generalized Myasthenia Gravis
Candid Therapeutics 44
Testing effectiveness (Phase 2)Looking for participantsNCT07284420
What this trial is testing

ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod

Who this might be right for
AChR-Ab Seropositive Generalized Myasthenia GravisMyasthenia GravisMG+3 more
argenx 70
Large-scale testing (Phase 3)UnknownNCT05332210
What this trial is testing

Evaluate the Safety of HBM9161 (HL161) Subcutaneous Injection in Patients With Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Harbour BioMed (Guangzhou) Co. Ltd. 144
Large-scale testing (Phase 3)Study completedNCT02301624
What this trial is testing

Extension Study of ECU-MG-301 to Evaluate Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis

Who this might be right for
Refractory Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc. 117
Large-scale testing (Phase 3)Looking for participantsNCT06392386
What this trial is testing

Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
argenx 12
Load More Results